Malecare presents to you a chance to make $125 for yourselves and $100 for Malecare. We usually do not participate in these market research headhunts, but, this one seems ok, brief in time and, it actually will help Malecare. We are currently trying to raise money to improve our website, malecare.com . Schlesinger Associates, a [...]
There was an interesting study done at the Department of Primary Care, Höglandssjukhuset, Nässjö, Sweden and the Department of Urology, Sahlgrenska University Hospital/SU Sahlgrenska, Gothenburg, Sweden. The study attempted to understand how men who are newly diagnosed with advanced prostate cancer are affected by fatigue before the side effects of any treatment has an impact [...]
The following letter has been sent to the ranking members of the U.S. Senate who have been responsible for spearheading the health care reforms. Not only do I wish to share with you the actual letter, but I want you to take note of the wide level of support that these concerns have created within [...]
Men with metastatic hormone-refractory prostate cancer (mHRPC) who become docetaxel-refractory (no longer responsive to docetaxel therapy have no approved second line chemotherapy available. One could say that they have reached the proverbial brick wall. Where to go and what to do is not at all clear. Most of us do not want to just roll [...]
My post of July 9, 2009, "Will Provenge or Any Treatment for Advanced Prostate Cancer Survive Health Reform?" has caused my mailbox to become full of a number of emails both damming my concern about health care reform and supporting the concern. The negative responses have ranged from calling me selfish to being a tool [...]